GlassScriptPhysician profile
Ingrid Anne Simonson
NPI 1750986964
$1,208.79
in general payments reported to CMS, 2019-2025
14 companies · $320 in 2025
The $320 reported for 2025 was more than what 90% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $130 · 2023: $348 · 2024: $226 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $545.55 | 2022-2025 | |
| Biogen, INC. | $121.56 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $92.06 | 2021 | |
| Exeltis, USA INC. | $87.55 | 2021-2024 | Slynd |
| Organon LLC | $84.12 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.92 | 2021-2023 | |
| Agile Therapeutics, INC. | $45.55 | 2021-2022 | |
| Evofem Biosciences, INC. | $41.36 | 2022-2023 | Phexxi |
| Hologic Sales and Service, LLC | $24.83 | 2023 | Myosure Tissue Removal Device |
| Shield Therapeutics INC | $21.72 | 2023 | Accrufer |
| Mycovia Pharmaceuticals, INC. | $20.72 | 2023 | Vivjoa |
| Smith+Nephew, INC. | $17.32 | 2025 | "Acticoat 4"" X 4""", Pico 14 |
| Takeda Pharmaceuticals U.S.A., INC. | $15.68 | 2023 | Trintellix |
| Coopersurgical, INC. | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ingrid Simonson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.